α1- and α2-adrenoreceptor antagonists in streptozotocin- and vincristine-induced hyperalgesia

Pharmacological Reports

Volumn 60, Issue 4, 2008, Pages 499-507

  Bujalska, Magdalena ^a   Araźna, Monika ^a   Makulska Nowak, Helena ^a   Gumułka, Stanisław W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adrenergic system; Hyperalgesia; Prazosin; Rats; Streptozotocin; Vincristine; Yohimbine

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; PRAZOSIN; STREPTOZOCIN; VINCRISTINE SULFATE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFICACY; HYPERALGESIA; MALE; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PAIN THRESHOLD; RAT; STREPTOZOCIN DIABETES;

EID: 52049093246     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aley KO, Levine JD: Different peripheral mechanisms mediate enhanced nociception in metabolic and traumatic painful peripheral neuropathies in the rat. Neuroscience, 2002, 111, 389-397.
2. Aley KO, Reichling DB, Levine JD: Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience, 1996, 73, 259-265.
3. Bitar MS, Bajic KT, Farook T, Thomas MI, Pitcher CW: Spinal cord noradrenergic dynamics in diabetic and hypercortisolaemic states. Brain Res, 1999, 830, 1-9.
4. 2-adrenoreceptor-mediated nociception in experimental diabetes. Pharmacol Biochem Behav, 1997, 56, 15-20.
5. 2-adrenergic receptors. J Neurophysiol, 1998, 80, 2244-2254.
6. Bujalska M: Effect of cyclooxygenase and NO synthase inhibitors administered centrally on antinociceptive action of acetaminophen (Part II). Pol J Pharmacol, 2003, 55, 1001-1011.
7. Bujalska M, Tatarkiewicz J, de Corde A, Gumułka W: Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hypeialgesia in rats. Pharmacology, 2008, 81, 151-157.
8. Bujalska M, Tatarkiewicz J, Gumułka SW: Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy. Pharmacology, 2008, 81, 158-163.
9. Byas-Smith MG, Max MB, Muir J, Kingman A: Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain, 1995, 60, 267-274.
10. Calixto JB, Cabrini DA, Ferreira J, Campos MM: Kinins in pain and inflammation. Pain, 2000, 87, 1-5.
11. Chabner BA, Allegra CJ, Curt GA, Calabresi P: Antineoplastic agents. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. Ed. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, McGraw-Hill, New York, 1996, 1233-1287.
12. 1-adrenoceptor antagonist treatment: interactions with the nitric oxide system. Eur J Pharmacol, 1998, 343, 217-223.
13. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A: Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain, 1994, 57, 153-160.
14. Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, Zhang JM: Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res, 2003, 960, 174-183.
15. Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA: Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care, 2000, 23, 510-517.
16. 2-Adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons. Pain, 1997, 69, 179-190.
17. Hong S, Morrow TJ, Paulson PE, Isom LL, Wiley JW: Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem, 2004, 279, 29341-29350.
18. Hong S, Wiley JW: Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J Biol Chem, 2005, 280, 618-627.
19. Kim SK, Min BI, Kim JH, Hwang BG, Yoo GY, Park DS, Na HS: Individual differences in the sensitivity of cold allodynia to phentolamine in neuropathic rats. Eur J Pharmacol, 2005, 523, 64-66.
20. Lee DO, Chung K, Chung IM: Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model. Neuroreport, 1997, 8, 3453-3456.
21. Lee YH, Ryu TG, Park SJ, Yang EJ, Jeon BH, Hur GM, Kim KJ: Alpha1-adrenoceptors involvement in painful diabetic neuropathy: a role in allodynia. Neuroreport, 2000, 11, 1417-1420.
22. Liu J, Wang KM, He LZ, Cao DY: Effects of sympathetic efferent in diabetic hyperalgesia in rat. Sheng Li Xue Bao, 1946, 48, 536-542.
23. Micromedex: Drugdex Drug Evaluations: Vincristine. Monograph in database on CD: "Micromedex® Healthcare Series", 2002, Vol. 112. Copyright: Micromedex Thomson Health Care.
24. Milan MJ: Descending control of pain. Prog Neurobiol, 2002, 66, 355-474.
25. Motsch J, Kamler M: α2-Adrenergic agonists. Use in chronic pain - a meta-analysis. Schmerz, 1997, 11, 339-344.
26. Nakagawa I, Omote K, Kitahata LM, Collins JG, Murata K: Serotonergic mediation of spinal analgesia and its interaction with noradrenergic systems. Anesthesiology, 1990, 73, 474-478.
27. Nakhoda A, Wong HA: The induction of diabetes in rats by intramuscular administration of streptozotocin. Experientia, 1979, 35, 1679-1680.
28. Ramesh B, Pugalendi KV. Influence of umbelliferone on membrane-bound AtPases in streptozotocin-induced diabetic rats. Pharmacol Rep, 2007, 59, 339-348.
29. Randall LO, Selitto JJ: A method for measurement of analgesic activity of inflamed tissue. Arch Int Pharmacodyn Ther, 1957, 111, 409-419.
30. Reddy R, Yaksh TL: Spinal noradrenergic terminal system-mediated antinociception. Brain Res, 1980, 189, 319-401.
31. Romanovsky D, Hastings SL, Stimers JR, Dobretsov M: Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes. J Peripher Nerv Syst, 2004, 9, 62-69.
32. Suzuki Y, Sato J, Kawanishi M, Mizumura K: Lowered response threshold and increased responsiveness to mechanical stimulation of cutaneous nociceptive fibers in streptozotocin-diabetic rat skin in vitro - correlates of mechanical allodynia and hyperalgesia observed in the early stage of diabetes. Neurosci Res, 2002, 43, 171-178.
33. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculation with Computer Programs, 2nd edn., Springer, New York, 1986.
34. Tanner KD, Levine JD, Topp KS: Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol, 1998, 395, 481-492.
35. Teasell RW, Arnold JM: Alpha-1 adrenoceptor hyperresponsiveness in three neuropathic pain states: complex regional pain syndrome 1, diabetic peripheral neuropathic pain and central pain states following spinal cord injury. Pain Res Manag, 2004, 9, 89-97.
36. Topp KS, Tanner KD, Levine JD: Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol, 2000, 424, 563-576.
37. 2-adrenoreceptors on post-ganglionic sympathetic terminals. Pain, 1995, 60, 317-327.